Health Genomics

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has emerged as a revolutionary tool for genome editing, enabling scientists to probe biological function, dissect genetic mechanisms, and potentially treat diseases. This technology, for which biochemists Jennifer Doudna and Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry, has garnered significant attention due to its potential,

Metagenomics is the study of genetic material recovered directly from environmental or clinical samples by a method called sequencing. The broad field may also be referred to as environmental genomics, ecogenomics, community genomics, or microbiomics. Metagenomics is often used to study a specific community of microorganisms, such as those residing on human skin, in the

Genome Intelligence :- Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming the field of genomics, enabling researchers to analyse vast amounts of genomic data and identify patterns that were previously difficult to detect. AI and ML are being used in various applications, including disease research, genomic tools like CRISPR, and precision medicine. The

Engineering the next generation of cell-based therapeutics is a rapidly evolving field that aims to overcome the challenges faced by current cell therapies, such as identifying the appropriate cell source, generating a viable and potent product, and developing scalable manufacturing processes. Some of the strategies being leveraged to enhance cell therapies include: Synthetic biology :

Genomics is being used to study COVID-19 in various ways, including identifying virus strains, understanding their impact on patients, and developing public health responses. Genomic sequencing is used to identify SARS-CoV-2 variants, allowing scientists to track the virus’s evolution and monitor important variants. Advancements in genomics have significantly contributed to the scientific understanding and public